NCT03470337View on ClinicalTrials.gov

Phlogenzym® in Patients With Acute Thrombophlebitis - Efficacy and Tolerance

PHASE3CompletedINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

September 30, 1996

Primary Completion Date

June 30, 1997

Study Completion Date

June 30, 1997

Conditions
Thrombophlebitis Leg
Interventions
DRUG

Phlogenzym

Bromelain / Trypsin / Rutoside

OTHER

Placebo

Trial Locations (1)

61032

Dr. Baumueller, Fano

All Listed Sponsors
lead

Mucos Pharma GmbH & Co. KG

INDUSTRY

NCT03470337 - Phlogenzym® in Patients With Acute Thrombophlebitis - Efficacy and Tolerance | Biotech Hunter | Biotech Hunter